Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes
A large retrospective cohort study found that GLP-1 receptor agonist use was associated with a lower risk of tuberculosis in people with type 2 diabetes compared with sulfonylureas, metformin, DPP-4…